PENTOMONE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H26O5
Molecular Weight	394.4602
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12CC3=CC=CC(OC)=C3O[C@]1([H])C(C)(C)[C@]4([H])OC5=C(OC)C=CC=C5C[C@]4([H])C2=O

InChI

InChIKey=MTJTVTZUEKVNTG-YJEDKTMASA-N

InChI=1S/C24H26O5/c1-24(2)22-15(11-13-7-5-9-17(26-3)20(13)28-22)19(25)16-12-14-8-6-10-18(27-4)21(14)29-23(16)24/h5-10,15-16,22-23H,11-12H2,1-4H3/t15-,16+,22-,23+

HIDE SMILES / InChI

Description
Sources: Elks, J. (2014) The Dictionary of Drugs: Chemical Data, page 949, retrieved from: https://books.google.ru/books?id=0vXTBwAAQBAJ | Rose,D.R. (1979) Endocrinology of Cancer, page 183, retrieved from: https://books.google.ru/books?id=gZBrAAAAMAAJ

Pentomone is a nonsteroidal antiandrogen developed by Lilly Company for postmenopausal patients with metastatic breast cancer who have been previously treated with tamoxifen. It is a prostate growth inhibitor.

Originator

Approval Year

Name

Type

Language

PENTOMONE

Official Name

English

PENTOMONE [USAN]

Common Name

English

COMPOUND-113935

Code

English

5AH,13H-(1)BENZOPYRANO(3,2-B)XANTHEN-13-ONE, 6,6A,12,12A,13A,14-HEXAHYDRO-4,8-DIMETHOXY-6,6-DIMETHYL-, (5A.ALPHA.,6A.ALPHA.,12A.ALPHA.,13A.ALPHA.)-

Common Name

English

pentomone [INN]

Common Name

English

COMPOUND 113935

Code

English

6,6aα,12,12aα,13aα,14-Hexahydro-4,8-dimethoxy-6,6-dimethyl-5aαH,13H-[1]benzopyrano[3,2-b]xanthen-13-one

Common Name

English

Code System Code Type Description

FDA UNII

OPS67T329P